Oncothyreon

With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
Endpoints
Wed, 12/7/16 - 10:16 am
Oncothyreon
Cascadian
tucatinib
ONT-380
treatment-resistant breast cancer
breast cancer
Oncothyreon reports 2Q loss
Yahoo/AP
Fri, 08/7/15 - 08:48 am
Oncothyreon
earnings
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
biotech
ASCO
Immunogen
Exelixis
Oncothyreon
CTI BioPharma
Immunomedics
Vascular Biogenics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
ASCO
Oncothyreon
Immunogen
Bristol-Myers Squibb
Merck
Clovis Oncology
Roche
CTI BioPharma
Celldex Therapeutics
Puma Biotechnology
Express Scripts
6 Key Cancer Winners From ASCO Presentations
24/7 Wall St
Mon, 06/1/15 - 10:06 am
ASCO
Immunogen
mirevtuximab soravtansine
ONT-380
Oncothyreon
cabozantinib
Exelixis
VB-111
Vascular Biogenics
Immunomedics
sacituzumab govitecan
pacritinib
CTI BioPharma
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
TheStreet.com
Mon, 06/1/15 - 09:43 am
Oncothyreon
breast cancer
ASCO
ONT-380
HER2-positive metastatic breast cancer
Pharma Stocks To Keep An Eye On: Pozen Inc. (POZN), Paratek Pharmaceuticals (PRTK), Oncothyreon Inc. (ONTY), Tetraphase Pharmaceuticals (TTPH)
Bidness Etc.
Thu, 12/18/14 - 10:07 am
Pozen
Tetraphase Pharmaceuticals
Paratek
Oncothyreon
Clinical failure for Merck KGaA's cancer vaccine dents subpopulation hopes
Fierce Biotech
Tue, 08/19/14 - 04:24 pm
vaccines
Merck KGaA
Oncothyreon
non-small cell lung cancer
Stimuvax
Merck Launches Hail Mary Lung Cancer Trial
Motley Fool
Wed, 04/9/14 - 09:24 am
Merck KGaA
tecemotide
Oncothyreon
non-small cell lung cancer
Oncothyreon is a potential target of Merck KGaA, says Cowen
Yahoo/Fly on the Wall
Wed, 09/25/13 - 10:33 am
M&A
Oncothyreon
Merck KGaA
Merck KGaA to continue testing cancer vaccine
Reuters
Wed, 09/25/13 - 08:44 am
vaccines
Merck KGaA
Stimuvax
Oncothyreon
non-small cell lung cancer
Oncothyreon A Speculative Buy
Seeking Alpha
Sat, 05/18/13 - 12:13 pm
Oncothyreon
ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine
TheStreet.com
Thu, 05/16/13 - 10:38 am
ASCO
lung cancer
vaccines
Oncothyreon
Stimuvax
Merck KGaA
Melanoma: Battle Of 3 Cancer Vaccines
Seeking Alpha
Tue, 04/23/13 - 03:31 pm
melanoma
vaccines
Amgen
Celldex
Oncothyreon
OncoSec
Vical
Oncothyreon Earnings: An Early Look
Motley Fool
Tue, 03/12/13 - 11:42 am
earnings
Oncothyreon
A Triple Play Of Biotech Disappointments Last Week
Investopedia
Fri, 12/28/12 - 11:45 am
Amicus
Hemispherx Biopharma
GSK
Oncothyreon
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 12/22/12 - 12:25 pm
Oncothyreon
Amicus Therapeutics
Herbalife
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Mon, 11/19/12 - 02:00 pm
Oncothyreon
Celsion
Arena Pharmaceuticals
NuPathe
Hemispherx
Amarin
Biogen Idec
Gilead
Hyperion Therapeutics
Celgene
Raptor Pharmaceuticals
Dynavax
Zogenix
Impax Labs
Merck KGaA expects to publish Stimuvax data in Q1 2013
Reuters
Thu, 11/15/12 - 11:09 am
Merck KGaA
Stimuvax
vaccines
cancer
Oncothyreon

Pages